A progressive and gradual attack on your central nervous system, Multiple Sclerosis is a chronic disease which affects parts of the body, with some people requiring help to live from day to day. The severity of their diseases can actually lead some sufferers to not even being able to move some parts of their body. A quick look into Multiple Sclerosis as a disease can be found here.
Multiple Sclerosis news 25 August 2017 – the high price of MS
- Rationalizing The Cost Of Drugs, Why Drugs Cost So Much
In an article published by Motley Fool, we get a quick look into a case of rationalization and justification on the high price of drugs, laying the blame on the way the system works. One thing which stood out in the report was the fallacy between R&D and the potential to create new and novel drugs. We took issue with one specific comment on how drug companies take a ROI view with respect to research and development of drugs, as the threat of no advances in treatment of a disease is one which is real, and highly plausible in the current landscape.
- Large Scale Research Study By Novartis On MS Via Smartphones
In perhaps one of the surprising, or not so surprising movement by pharmaceutical companies to find out more about patients, Novartis has launched a large scale study on MS using Apple’s ResearchKit software. They are doing this study to better understand treatment effectiveness. I am hoping for a day where patients can be rewarded with the information they provide to help companies come up with new drugs, as every time a drug is out on the market, companies make a lot of money.
In perhaps one of the most somber and serious coverage of the state of the medical and pharmaceutical landscape, we once against witness the massive Goliath and realized that without sufficient supports from millions of David, it will be hard to triumph against established practices and traditions.